---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-045385"
form_type: "8-K/A"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:25:19.271531+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Beauty Health Company CEO Marla Beck Terminated Without Cause, Enters Separation Agreement

## Summary
- Marla Beck terminated as CEO, President, and director effective September 30, 2025, without cause and with no disagreement on Company matters.
- Separation agreement provides 18 months of base salary continuation, prorated 2025 annual bonus, and COBRA premium reimbursement for up to 18 months.
- Performance share units with a grant-date value of $1,700,000 vest fully on the separation date.
- Beck will serve as a consultant from October 1 through December 31, 2025, receiving $250,000 paid bi-weekly and counting toward 2025 annual incentive plan.
- Company will reimburse up to $10,000 in legal fees; Beck signed a general release of all claims.

## SEC filing metadata
- accession: 0001628280-25-045385
- form_type: 8-K/A
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828025045385/0001628280-25-045385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828025045385/skin-20250926.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-045385
- JSON: https://secwatch.observer/filing/0001628280-25-045385.json
- Plain text: https://secwatch.observer/filing/0001628280-25-045385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.